The report "Global Infertility Treatment Market" accounted to USD 1.21 billion in 2016 growing at a CAGR of 10.8% during the forecast period of 2017 to 2024.
Global Infertility Treatment Market By Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male, Female), End User (Fertility Clinics, Hospitals, Cryobanks), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Infertility treatment is required when there is inability to conceive. Ovulation problems could lead to infertility in females whereas deficiency in semen leads to male infertility.
This market provides numerous treatment methods such as Assisted Reproductive Technology (ART), DNA fragmentation, surrogacy, in-vitro diagnosis, Zygote Intrafallopian Transfer (ZIFT) and many more.
Major market drivers and restraints:
- Increasing number of fertility clinic
- Declining in fertility rate
- Technological advancement
- Rising public awareness
- High procedural cost of assisted reproductive techniques
On the basis of procedure, global infertility treatment market is segmented into ART, artificial insemination, IVF, surrogacy and fertility surgery.
ART segment accounted the largest market share in 2016 due to its high success rate, increasing infertility and lifestyle disorders.
On the basis of product, global infertility treatment market is segmented into instruments, media and accessories. In 2016, instruments segment has witnessed the largest market share.
On the basis of patient type, global infertility treatment market is segmented into male and female.
On the basis of end user, global infertility treatment market is segmented into fertility clinics, hospitals and cryobanks.
On the basis of geography, global infertility treatment market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
In 2017, North America is expected to dominate the market.
The global infertility treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes continuous manufacturing market shares for global, Europe, North America, Asia Pacific, and South America.
Major Market Competitors:
Some of the major players operating in global infertility treatment market are The Cooper Companies Inc., VitrolifeAB, GeneaLimited, COOK, Esco Micro Pte. Ltd, Thermo Fisher Scientific, Inc., IVFtech ApS, The Baker Company, Irvine Scientific, Hamilton Throne Inc., Zander scientific Inc., LABOTECT GMBH, SOMATEX Medical Technologies GmbH, INVOBioscience, IHMedical A/S, RI.MOS, BIOGENICS INC., SurelifePteLtd., and Nikon Instruments Inc.
Read more about the Global Infertility Treatment Market at databridgemarketresearch.com/repor…treatment-market/
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: